Cite
HARVARD Citation
Dimopoulos, M. et al. (2023). Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology. 41 (8), pp. 1590-1599. [Online].